The pathophysiology of irritable bowel syndrome;Physiopathologie du syndrome de l'intestin irritable

Tunisie Medicale

Volumn 84, Issue 5, 2006, Pages 269-274

  Zouiten Mekki, Lilia ^a,b   Karoui, Sami ^b   Boubaker, Jalel ^b   Fekih, Monia ^b   Mechmeche, Rachid ^a   Filali, Azza ^b  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b LA RABTA HOSPITAL   (Tunisia)

Author keywords

Brain gut axis; Irritable bowel syndrome; Pathophysiology

Indexed keywords

NEUROTRANSMITTER;

ABDOMINAL PAIN; COST; DEFECATION HABIT; ENVIRONMENTAL FACTOR; GASTROINTESTINAL DISEASE; HUMAN; IRRITABLE COLON; REVIEW; SOCIAL PSYCHOLOGY;

BRAIN; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME; NEURAL PATHWAYS; NEUROTRANSMITTER AGENTS;

EID: 33747036659     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Drossman DA, Camilleri M, Mayer E, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31.
2. Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology. 2002; 122: 1701-14.
3. Hatlebakk JG, Hatlebakk MV. Diagnostic approach to suspected irritable bowel syndrome. Best Pract. Res. Clin. Gastroenterol. 2004; 18: 735-46.
4. Tomasz M. The brain gut axis in irritable bowel syndrome- clinical aspects. Med. Sci. Monit. 2004; 10: 125-131.
5. Boeckxstaens GR. Understanding and controlling the enteric nervous system. Best. Pract. Res. Clin. Gastroenterol. 2002; 16: 1013-23.
6. Delvaux M. Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome. Best Pract. Res. Clin. Gastroenterol. 2004; 18: 747-71.
7. Camilleri M, Heading RC, Thompson WG. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment. Pharmacol. Ther. 2002; 16: 1407-30.
8. Borody T, Byrnes D, Bell D, Henderson L. The migrating motor complex. Its relation to circulating CCK, motilin and pancreatic polypeplide in irritable bowel disease patients and controls. Clin. Res. 1984; 32: 23A.
9. Kellow JE, Gill RC, Wingate DL. Prolonged ambulant recording of small bowel motiliy demonstrate abnormalities in irritable bowel syndrome. Gastroenterology. 1990; 98: 1208-18.
10. Cann PA, Read NW, Brown C. Irritable bowel syndrome relationship of disorders in the transit of a single solid meal to symptom patterns. Gut. 1983: 405-11.
11. Lasser RB, Bond JH, Levin MD. The role of intestinal gas in functional abdominal pain. N. Engl. J. Med. 1975; 293: 524-6.
12. Whitehead WE, Holtkotter B, Enck P, et al. Tolerance of rectosigmoid distension in irritable bowel syndrome. Gastroenterology. 1990; 98: 1187-92.
13. Trimble JGC, Farouk R, Pryde A, et al. Heightened visceral sensation in functional gastrointestinal disease is not site specific. Evidence for a generalized disorder of gut sensitivity. Dig. Dis. Sci. 1995; 40: 1607-13.
14. Mertz H. Visceral hypersensitivity. Aliment. Pharmacol. Ther. 2003; 17: 623-633.
15. Chadwick NA, Trueloves C. The irritable bowel syndrome. Q. J. Med. 1962; 31: 307-322.
16. Read NW. Rectal distension from sensation to feeling. Gastroenterology. 2000: 118: 972-74.
17. Porcelli P. Psychological abnormalities in patients with irritable bowel syndrome. Indian J. Gastroenterol. 2004; 23: 63-69.
18. Guigley EM. Current concepts of the irritable bowel syndrome. Scand. J. Gastroenterol. 2003; 237: 1-8.
19. Thalley NJ, Spiller R. irritable bowel syndrome: a little understood organic bowel disease? Lancet. 2002; 360: 555-64.
20. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002; 122: 1778-83.
21. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrin cells, Tlymphocytes and increased gut permeability following acute campylobacter enteritis and post dysenteric irritable bowel syndrome. Gut. 2000; 47: 804-11.
22. Palsson OS, Morteau O, Bozynski EM, et al. Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Dig. Dis. Sci. 2004; 49: 1236-43.
23. Dunlop SP, Jenkins D, Spiller RC. Age related decline in rectal mucosal lymphocytes and mast cells. Eur. J. Gastroenterol Hepatol. 2004. Oct: 16: 1011-5.
24. Lin HC. Small intestinal bacterial overgrowth a framework for understanding irritable bowel syndrome. JAMA. 2004; 292: 852-8.
25. Verdu EF, Collins SM. Irritable bowel syndrome. Best Pract. Res. Clin. Gastroenterol. 2004; 18: 315-21.
26. Gwee KA, Graham JC, Mckendriek MW, et al. Psychometric scores and persistence of irritable bowel syndrome after infectious diarrhea. Lancet. 1996; 347: 150-153.
27. Wood JD. Enteric nervous system, serotonin and the irritable bowel syndrome. Curr. Opin. Gastroenterol. 2001; 17: 91-97.
28. Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev. Gastroenterol. Disord. 2003; 3: S25-S34.
29. Hillsley K, Kirkup AJ, Grundy D. Direct and indirect actions of 5 hydroxytryptophane on the discharge of meseineric afferent fibers innervating the rat jejunum. J. Physiol. 1998; 506: 551-61.
30. Humphrey PPA, Bountra C, Clayton N, Kozlowski K. The therapeutic potential of 5HT3 receptor antagonists in the treatment of irritable bowel syndrome. Aliment. Pharmacol. Ther. 1999; 13: 31-38.
31. Coutinho S, Urban M, Gebhart G. The role of CNS NMDA receptors and nitric oxid in visceral hyperalgesis. Eur. J. Pharmacol. 2001; 429: 319-25.
32. Julia V, Su X, Bueno L, et al. Role of neurokinin 3 receptors on responses to colorectal distension in the rat. Electrophysiological and behavioral studies. Gastroenterology. 1999; 116: 1124-31.
33. Tache Y, Martinez V, Million M, et al. Stress and the gastrointestinal tract. Stress related alteration of gut motor function. Role of brain corticotrophin releasing factor receptors. Am. J. Physiol. 2001; 280: 173-7.